潤達醫療(603108.SH)業績快報:前三季度淨利降19.25%至2.36億元
格隆匯 10 月 16日丨潤達醫療(603108.SH)披露2020年前三季度業績快報,實現營業總收入49.25億元,同比下降5.16%;營業利潤4.56億元,同比下降22.14%;利潤總額4.58億元,同比下降22.67%;歸屬於上市公司股東的淨利潤2.36億元,同比下降19.25%;基本每股收益0.41元。
影響經營業績的主要原因繫上半年公司主營業務受疫情影響,醫院常規檢測需求階段性下滑。隨着國內疫情得到有效防控,第三季度公司各項業務快速恢復。具體分析如下:
(1)進入第三季度,醫院門診量及住院量逐步恢復,公司各項業務快速恢復,第三季度實現營業收入19.81億元,較去年同期增長4.41%,實現歸屬於上市公司股東的淨利潤1.25億元,較去年同期增長6.07%。
(2)分地區來看,第三季度華中地區、西南地區、華東地區、華北地區營業收入均較同期實現增長,恢復較快;東北地區仍處於恢復中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.